Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

Serratia marcescens bacteremia traced to an infused narcotic

Abstract

BACKGROUND: From June 30, 1998, through March 21, 1999, several patients in the surgical intensive care unit of a hospital acquired Serratia marcescens bacteremia. We investigated this outbreak.

METHODS: A case was defined as the occurrence of S. marcescens bacteremia in any patient in the surgical intensive care unit during the period of the epidemic.… Read more

Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge

Abstract

OBJECTIVE: To investigate a perceived increase in central venous catheter (CVC)-associated bloodstream infections (BSIs) among pediatric hematology-oncology outpatients.

DESIGN: A case-control study.

SETTING: A pediatric hematology-oncology outpatient clinic at Fresno Children’s Hospital.

PATIENTS: Pediatric hematology-oncology clinic outpatients with CVCs at Fresno Children’s Hospital between November 1994 and October 1997.… Read more

Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

The evolving world of healthcare-associated bloodstream infection surveillance and prevention: is your system as good as you think?

Abstract

Jarvis WR

Infect Control Hosp Epidemiol 2002 May;23(5):236-8

PMID: 12026146

The evolving world of healthcare-associated bloodstream infection surveillance and prevention: is your system as good as you think? was last modified: September 28th, 2015 by Jarvis WR… Read more
Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

Vitamin A levels and immunity in humans

Abstract

In animal studies, vitamin A deficiency induces a shift from type 2 (humoral, Th2) to type 1 (cellular, Th1) cytokines; there are no similar data for humans. Control of human immunodeficiency virus (HIV) and Mycobacterium tuberculosis infections requires type 1 cytokine (cellular) immunity.… Read more